FibroGen Inc (FGEN)
0.39
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 11:22
FibroGen 1 Year Total Returns (Daily): -20.87% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | -20.87% |
November 20, 2024 | -33.85% |
November 19, 2024 | -38.65% |
November 18, 2024 | -40.86% |
November 15, 2024 | -34.46% |
November 14, 2024 | -23.07% |
November 13, 2024 | -20.03% |
November 12, 2024 | 1.71% |
November 11, 2024 | -10.92% |
November 08, 2024 | -32.14% |
November 07, 2024 | -43.37% |
November 06, 2024 | -44.49% |
November 05, 2024 | -52.58% |
November 04, 2024 | -49.74% |
November 01, 2024 | -41.71% |
October 31, 2024 | -44.29% |
October 30, 2024 | -36.66% |
October 29, 2024 | -35.69% |
October 28, 2024 | -37.24% |
October 25, 2024 | -42.40% |
October 24, 2024 | -38.22% |
October 23, 2024 | -36.90% |
October 22, 2024 | -36.29% |
October 21, 2024 | -31.88% |
October 18, 2024 | -34.17% |
Date | Value |
---|---|
October 17, 2024 | -39.36% |
October 16, 2024 | -39.49% |
October 15, 2024 | -40.44% |
October 14, 2024 | -42.34% |
October 11, 2024 | -49.36% |
October 10, 2024 | -57.32% |
October 09, 2024 | -54.49% |
October 08, 2024 | -56.36% |
October 07, 2024 | -54.48% |
October 04, 2024 | -51.09% |
October 03, 2024 | -46.10% |
October 02, 2024 | -50.63% |
October 01, 2024 | -54.57% |
September 30, 2024 | -53.71% |
September 27, 2024 | -57.64% |
September 26, 2024 | -55.06% |
September 25, 2024 | -55.66% |
September 24, 2024 | -51.20% |
September 23, 2024 | -52.68% |
September 20, 2024 | -53.28% |
September 19, 2024 | -47.44% |
September 18, 2024 | -46.84% |
September 17, 2024 | -48.08% |
September 16, 2024 | -47.61% |
September 13, 2024 | -49.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.65%
Minimum
Nov 10 2023
119.4%
Maximum
May 09 2023
-31.76%
Average
-40.49%
Median
1 Year Total Returns (Daily) Benchmarks
Biomarin Pharmaceutical Inc | -27.95% |
Arbutus Biopharma Corp | 89.07% |
GlycoMimetics Inc | -78.67% |
Cidara Therapeutics Inc | 19.11% |
Cue Biopharma Inc | -56.72% |